Manufacturer Supply High Quality CAS 35807-85-3 Tauroursodeoxycholic Acid Sodium Salt

• Powder: Yes
• Customized: Customized
• Certification: GMP, USP
• Suitable for: Tauroursodeoxycholic Acid Sodium Salt
• State: Powder
• Purity: >99%
• Model NO.: HRK-Tauroursodeoxycholic Acid Sodium Salt
• Product Name: Tauroursodeoxycholic Acid Sodium Salt
• Appearance: White Fine Powder
• Certificate: GMP ISO USP Bp
• Assay: 90% Min Tauroursodeoxycholic Acid Sodium Salt
• Test: HPLC
• Mf: C26h44nnao6s
• MW: 521.69
• Active Ingredient: Tauroursodeoxycholic Acid Sodium Salt
• Sample: Tauroursodeoxycholic Acid Sodium Salt Avaliable
• Grade Standard: Medicine Grade
• Application: Pharmaceutical Intermediate
• Type of Product: Auxiliaries and Other Medicinal Chemicals
• Storage: Cool Dry Place
• Shelf Life: 2 Years Proper Storage
• Place of Origin: Shaanxi, China
• Transport Package: 1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
• Specification: 99% min Tauroursodeoxycholic Acid Sodium Salt
• Trademark: Henrikang
• Origin: Shaanxi China
• Production Capacity: 500000kg/Year

Product Description

Manufacturer Supply High Quality CAS 35807-85-3 Tauroursodeoxycholic Acid Sodium Salt

Product Name	Wholesale High Quality Tauroursodeoxycholic Acid Sodium Salt CAS 35807-85-3
CAS	35807-85-3
Appearance	White Fine Powder
Molecular Weight	521.69
Assay	99% Tauroursodeoxycholic Acid Sodium Salt
Shelf Life	24 months when properly stored
Storage	Keep in a cool, dry, dark location

What is Tauroursodeoxycholic Acid Sodium Salt  ? Biological activity: SodiumTauroursodeoxycholate (TUDC) is a kind of water-soluble bile acid, used in the treatment of gallstones and liver cirrhosis. Target ERKCaspase-3Caspase-12 In vitro Studies In vitro, Tauroursodeoxycholate showed protection and reversal of 17βEG induced cVA-of-CLF injury. In Mz - ChA - 1 bile duct cancer cells, TauroursodeoxycholateChemicalbook through Ca in rat liver cells in vitro, Tauroursodeoxycholate formed by beta 1 - integrin mediated cAMP, suppress the apoptosis induced by bile acid. In vivo studies in rats with ghost cypeptide-induced bile obstruction, Tauroursodeoxycholate(360μmol/kg,i.v.) significantly inhibited bile flow reduction and increased serum alkaline phosphatase, leucine aminopeptidase, and glutamic-pyruvic transaminase activities, as well as cholesterol, phospholipid, and bile acid concentrations.

Product Name	CAS No.	Product Name	CAS No.
Lufenuron	103055-07-8	Toltrazuril	69004-03-1
Nitenpyram	120738-89-8	Praziquantel/Biltricide	55268-74-1
Fenbendazole	43210-67-9	Tetramisole Hcl	5086-74-8
Levamisole	14769-73-4	Ponazuril	9004-4-2
Diclazuril	101831-37-2	Florfenicol	73231-34-2
Ivermectin	70288-86-7	Enrofloxacin Hcl	112732-17-9
Albendazole	54965-21-8	Mebendazole	31431-39-7